|
End-of-day quote
Xetra
2026-08-14
|
5-day change | 1st Jan Change | ||
| 130.44 EUR | -1.26% |
|
-3.62% | +10.32% |
| 08-13 | European Stocks Close Mixed in Thursday Trading; UK GDP Growth Slows in Q2 | MT |
| 08-13 | Novartis Wins UK Court Challenge to Entresto Patent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -1.26% | -3.62% | +10.32% | +23.78% | +62.36% | 287B |
-
|
-
|
-
|
- Stock Market
- Stocks
- NOVN Stock
- NOT Stock
- Charts Novartis AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
